• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机器学习的MRI成像用于前列腺癌诊断:系统评价与荟萃分析。

Machine learning-based MRI imaging for prostate cancer diagnosis: systematic review and meta-analysis.

作者信息

Zhao Yusheng, Zhang Lei, Zhang Subo, Li Jiajing, Shi Kaimin, Yao Di, Li Qiuzi, Zhang Tao, Xu Lei, Geng Lei, Sun Yi, Wan Jinxin

机构信息

Department of Medical Imaging, The Second People's Hospital of Lianyungang, Lianyungang city, China.

Department of Medical Imaging, Cancer Hospital of Lianyungang, Lianyungang city, China.

出版信息

Prostate Cancer Prostatic Dis. 2025 Jul 28. doi: 10.1038/s41391-025-00997-2.

DOI:10.1038/s41391-025-00997-2
PMID:40721879
Abstract

OBJECTIVE

This study aims to evaluate the diagnostic value of machine learning-based MRI imaging in differentiating benign and malignant prostate cancer and detecting clinically significant prostate cancer (csPCa, defined as Gleason score ≥7) using systematic review and meta-analysis methods.

METHODS

Electronic databases (PubMed, Web of Science, Cochrane Library, and Embase) were systematically searched for predictive studies using machine learning-based MRI imaging for prostate cancer diagnosis. Sensitivity, specificity, and area under the curve (AUC) were used to assess the diagnostic accuracy of machine learning-based MRI imaging for both benign/malignant prostate cancer and csPCa.

RESULTS

A total of 12 studies met the inclusion criteria, with 3474 patients included in the meta-analysis. Machine learning-based MRI imaging demonstrated good diagnostic value for both benign/malignant prostate cancer and csPCa. The pooled sensitivity and specificity for diagnosing benign/malignant prostate cancer were 0.92 (95% CI: 0.83-0.97) and 0.90 (95% CI: 0.68-0.97), respectively, with a combined AUC of 0.96 (95% CI: 0.94-0.98). For csPCa diagnosis, the pooled sensitivity and specificity were 0.83 (95% CI: 0.77-0.87) and 0.73 (95% CI: 0.65-0.81), respectively, with a combined AUC of 0.86 (95% CI: 0.83-0.89).

CONCLUSION

Machine learning-based MRI imaging shows good diagnostic accuracy for both benign/malignant prostate cancer and csPCa. Further in-depth studies are needed to validate these findings.

摘要

目的

本研究旨在采用系统评价和荟萃分析方法,评估基于机器学习的磁共振成像(MRI)在鉴别前列腺癌良恶性以及检测临床显著前列腺癌(csPCa,定义为 Gleason 评分≥7)方面的诊断价值。

方法

系统检索电子数据库(PubMed、Web of Science、Cochrane 图书馆和 Embase),查找使用基于机器学习的 MRI 成像进行前列腺癌诊断的预测性研究。采用灵敏度、特异度和曲线下面积(AUC)评估基于机器学习的 MRI 成像对前列腺癌良恶性及 csPCa 的诊断准确性。

结果

共有 12 项研究符合纳入标准,荟萃分析纳入 3474 例患者。基于机器学习的 MRI 成像对前列腺癌良恶性及 csPCa 均显示出良好的诊断价值。诊断前列腺癌良恶性的合并灵敏度和特异度分别为 0.92(95%CI:0.83 - 0.97)和 0.90(95%CI:0.68 - 0.97),合并 AUC 为 0.96(95%CI:0.94 - 0.98)。对于 csPCa 诊断,合并灵敏度和特异度分别为 0.83(95%CI:0.77 - 0.87)和 0.73(95%CI:0.65 - 0.81),合并 AUC 为 0.86(95%CI:0.83 - 0.89)。

结论

基于机器学习的 MRI 成像对前列腺癌良恶性及 csPCa 均显示出良好的诊断准确性。需要进一步深入研究以验证这些发现。

相似文献

1
Machine learning-based MRI imaging for prostate cancer diagnosis: systematic review and meta-analysis.基于机器学习的MRI成像用于前列腺癌诊断:系统评价与荟萃分析。
Prostate Cancer Prostatic Dis. 2025 Jul 28. doi: 10.1038/s41391-025-00997-2.
2
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment.前列腺特异性膜抗原正电子发射断层扫描在前列腺癌明确治疗前诊断和初始分期中作用的综合系统评价与荟萃分析
Eur Urol. 2025 Jun;87(6):654-671. doi: 10.1016/j.eururo.2025.03.003. Epub 2025 Mar 27.
3
Diagnostic Performance of Prostate-specific Antigen Density for Detecting Clinically Significant Prostate Cancer in the Era of Magnetic Resonance Imaging: A Systematic Review and Meta-analysis.基于磁共振成像时代下前列腺特异性抗原密度对临床显著前列腺癌的诊断性能:系统评价和荟萃分析。
Eur Urol Oncol. 2024 Apr;7(2):189-203. doi: 10.1016/j.euo.2023.08.002. Epub 2023 Aug 26.
4
Machine learning models for discriminating clinically significant from clinically insignificant prostate cancer using bi-parametric magnetic resonance imaging.使用双参数磁共振成像鉴别临床显著型与临床非显著型前列腺癌的机器学习模型
Diagn Interv Radiol. 2024 Oct 1. doi: 10.4274/dir.2024.242856.
5
Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.基于前列腺特异性膜抗原正电子发射断层扫描靶向活检对临床显著前列腺癌检测的诊断性能:系统评价和荟萃分析。
Eur Urol Oncol. 2022 Aug;5(4):390-400. doi: 10.1016/j.euo.2022.04.006. Epub 2022 Jun 15.
6
MRI-Based Radiomics Methods for Predicting Ki-67 Expression in Breast Cancer: A Systematic Review and Meta-analysis.基于MRI的放射组学方法预测乳腺癌中Ki-67表达:一项系统评价和荟萃分析
Acad Radiol. 2024 Mar;31(3):763-787. doi: 10.1016/j.acra.2023.10.010. Epub 2023 Nov 2.
7
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.多参数磁共振成像在前列腺穿刺活检中排除前列腺癌的阴性预测值是多少?来自欧洲泌尿外科学会前列腺癌指南小组的系统评价和荟萃分析。
Eur Urol. 2017 Aug;72(2):250-266. doi: 10.1016/j.eururo.2017.02.026. Epub 2017 Mar 21.
8
MRI software and cognitive fusion biopsies in people with suspected prostate cancer: a systematic review, network meta-analysis and cost-effectiveness analysis.磁共振成像软件联合认知融合活检用于疑似前列腺癌患者:系统评价、网络荟萃分析和成本效果分析。
Health Technol Assess. 2024 Oct;28(61):1-310. doi: 10.3310/PLFG4210.
9
Transabdominal ultrasound and endoscopic ultrasound for diagnosis of gallbladder polyps.经腹超声和内镜超声用于胆囊息肉的诊断。
Cochrane Database Syst Rev. 2018 Aug 15;8(8):CD012233. doi: 10.1002/14651858.CD012233.pub2.
10
AI-Assisted vs Unassisted Identification of Prostate Cancer in Magnetic Resonance Images.磁共振图像中人工智能辅助与非辅助前列腺癌识别
JAMA Netw Open. 2025 Jun 2;8(6):e2515672. doi: 10.1001/jamanetworkopen.2025.15672.

本文引用的文献

1
Comparison of the impact of rectal susceptibility artifacts in prostate magnetic resonance imaging on subjective evaluation and deep learning: a two-center retrospective study.前列腺磁共振成像中直肠敏感性伪影对主观评估和深度学习影响的比较:一项双中心回顾性研究
BMC Med Imaging. 2025 Feb 25;25(1):61. doi: 10.1186/s12880-025-01602-7.
2
Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRI.交互式可解释深度学习模型为 MRI 前列腺癌诊断提供信息。
Radiology. 2023 May;307(4):e222276. doi: 10.1148/radiol.222276. Epub 2023 Apr 11.
3
Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRI.
使用多参数磁共振成像的机器学习和深度学习预测前列腺癌侵袭性
Front Oncol. 2022 Jan 13;11:802964. doi: 10.3389/fonc.2021.802964. eCollection 2021.
4
Single-center versus multi-center biparametric MRI radiomics approach for clinically significant peripheral zone prostate cancer.单中心与多中心双参数MRI影像组学方法用于临床显著的外周带前列腺癌
Insights Imaging. 2021 Oct 21;12(1):150. doi: 10.1186/s13244-021-01099-y.
5
End-to-end prostate cancer detection in bpMRI via 3D CNNs: Effects of attention mechanisms, clinical priori and decoupled false positive reduction.基于 3D CNNs 的 bpMRI 端到端前列腺癌检测:注意力机制、临床先验知识和去耦假阳性减少的影响。
Med Image Anal. 2021 Oct;73:102155. doi: 10.1016/j.media.2021.102155. Epub 2021 Jun 29.
6
MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins.基于 MRI 的放射组学模型评估前列腺癌、包膜外侵犯和阳性手术切缘。
Cancer Imaging. 2021 Jul 5;21(1):46. doi: 10.1186/s40644-021-00414-6.
7
An integrated nomogram combining deep learning, Prostate Imaging-Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study.基于深度学习、前列腺影像报告和数据系统(PI-RADS)评分以及临床变量的列线图模型鉴别双侧磁共振成像前列腺癌的临床意义:一项回顾性多中心研究。
Lancet Digit Health. 2021 Jul;3(7):e445-e454. doi: 10.1016/S2589-7500(21)00082-0.
8
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
9
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020.全球及中国癌症负担的变化趋势:对《2020年全球癌症统计数据》的二次分析
Chin Med J (Engl). 2021 Mar 17;134(7):783-791. doi: 10.1097/CM9.0000000000001474.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.